ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IKA Ilika Plc

30.50
0.50 (1.67%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Ilika Plc LSE:IKA London Ordinary Share GB00B608Z994 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.67% 30.50 29.00 32.00 31.25 29.50 30.00 954,686 08:31:15
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 702k -7.3M -0.0459 -6.64 48.49M

Ilika plc Custom Cell Capability

29/05/2019 7:00am

RNS Non-Regulatory


TIDMIKA

Ilika plc

29 May 2019

Ilika plc

("Ilika" or the "Company")

Custom Cell Capability

Ilika (AIM: IKA), a pioneer in solid-state battery technology, announces that it has developed processing methods to enable rapid customisation of its Stereax thin film cells to match customers' requirements for form, fit and function.

The launch on 10(th) April 2019 of its Stereax(R) M50 mm-scale solid state batteries for MedTech was a defining step for Ilika's first product made using photolithography. This marked a move away from the use of contact masks, which were deployed to produce earlier Stereax products. Photolithography is a widely used microfabrication method in the semiconductor industry. It has the advantage over contact masks of being able to create smaller feature sizes, of less than a micron. The technique is therefore particularly suitable for forming Ilika's mm-scale range of Medtech batteries. In addition, the lead time for creating new wafer layouts is significantly reduced, by up to 85%, making it possible to respond to customers' requirements in an accelerated manner. Also, the operating costs of using a photolithographic process rather than contact masks are significantly less, in part due to the ability of photolithography to enable a tighter spacing of devices on wafers, increasing wafer yield.

Examples of MedTech devices which can benefit from Stereax battery technology are insulin pumps, cardiac devices, blood pressure monitors, neurostimulators, gastric stimulators, smart contact lenses and smart dental braces.

Relative to standard lithium ion batteries, Stereax solid state batteries are safer, have longer life spans of up to 10 years and lower leakage currents, making them suitable for low power wireless charging.

"The replacement of contact masks with a photolithographic method is an important step in being able to offer customised solutions to high value proprietary applications for Stereax products," added Ilika's CEO Graeme Purdy.

For more information contact:

 
Ilika plc 
Graeme Purdy, Chief Executive                           Tel: 023 8011 1400 
Steve Boydell, Finance Director 
 
Liberum Capital Limited                                 Tel: 020 3100 2000 
Andrew Godber, Trystan Cullen, 
 Cameron Duncan, William Hall 
 
Walbrook PR Ltd                  Tel: 020 7933 8780 / ilika@walbrookpr.com 
Paul McManus                                            Mob: 07980 541 893 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAUWUNRKNAVUAR

(END) Dow Jones Newswires

May 29, 2019 02:00 ET (06:00 GMT)

1 Year Ilika Chart

1 Year Ilika Chart

1 Month Ilika Chart

1 Month Ilika Chart

Your Recent History

Delayed Upgrade Clock